Anisimova_2025_Mol.Biol.Cell__mbcE24080342

Reference

Title : HaloPROTAC3 treatment activates the unfolded protein response of the endoplasmic reticulum in non-engineered mammalian cell lines - Anisimova_2025_Mol.Biol.Cell__mbcE24080342
Author(s) : Anisimova AS , Karagoz GE
Ref : Mol Biology of the cell , :mbcE24080342 , 2025
Abstract :

Proteins fused to HaloTag, an engineered haloalkane dehalogenase, can be depleted by a heterobifunctional degrader compound HaloPROTAC3. The binding of HaloPROTAC3 to both the HaloTag and the E3 ligase von Hippel-Lindau (VHL) brings them into proximity and mediates the degradation of the HaloTag fusion proteins. Here, we generated a colon cancer cell line HCT116 expressing HaloTag fused to the RNA-binding protein IGF2BP3 to study its function. HaloPROTAC3 treatment depleted 75% of HaloTag-IGF2BP3 in 5 hours. Transcriptomics revealed that HaloPROTAC3 treatment resulted in the destabilization of IGF2BP3 target mRNAs and activated the unfolded protein response (UPR). Surprisingly, we found that HaloPROTAC3 results in UPR activation in non-engineered mammalian cells. Our data demonstrate that HaloPROTAC3 causes mild endoplasmic reticulum stress independent of IGF2BP3 function and shall guide future studies using the HaloPROTAC3 protein depletion strategy.

PubMedSearch : Anisimova_2025_Mol.Biol.Cell__mbcE24080342
PubMedID: 40105918
Gene_locus related to this paper: rhoso-halo1

Related information

Inhibitor HaloPROTAC3
Gene_locus rhoso-halo1

Citations formats

Anisimova AS, Karagoz GE (2025)
HaloPROTAC3 treatment activates the unfolded protein response of the endoplasmic reticulum in non-engineered mammalian cell lines
Mol Biology of the cell :mbcE24080342

Anisimova AS, Karagoz GE (2025)
Mol Biology of the cell :mbcE24080342